Clin Endosc.  2018 Jan;51(1):5-7. 10.5946/ce.2018.016.

Can Contrast-Enhanced Harmonic Endoscopic Ultrasonography Differentiate Malignancy from Benign Disease?

• Lee TH

• KMID: 2403625
• DOI: http://doi.org/10.5946/ce.2018.016

Abstract

No abstract available.

MeSH Terms

Endosonography*

Reference

1. Kaufman AR, Sivak MV Jr. Endoscopic ultrasonography in the differential diagnosis of pancreatic disease. Gastrointest Endosc. 1989; 35:214–219.

2. Brugge WR. EUS. Gastrointest Endosc. 2013; 78:414–420.

3. Ishikawa H, Hirooka Y, Itoh A, et al. A comparison of image quality between tissue harmonic imaging and fundamental imaging with an electronic radial scanning echoendoscope in the diagnosis of pancreatic diseases. Gastrointest Endosc. 2003; 57:931–936.

4. Matsumoto K, Katanuma A. Novel tissue harmonic imaging clearly visualizes a case of intraductal papillary mucinous neoplasm with mural nodules. JOP. 2014; 15:274–275.

5. Kitano M, Yamashita Y. New imaging techniques for endoscopic ultrasonography: contrast-enhanced endoscopic ultrasonography. Gastrointest Endosc Clin N Am. 2017; 27:569–583.

6. Leem G, Chung MJ, Park JY, et al. Clinical value of contrast-enhanced harmonic endoscopic ultrasonography in the differential diagnosis of pancreatic and gallbladder masses. Clin Endosc. 2018; 51:80–88.

7. Lee TY, Cheon YK, Shim CS. Clinical role of contrast-enhanced harmonic endoscopic ultrasound in differentiating solid lesions of the pancreas: a single-center experience in Korea. Gut Liver. 2013; 7:599–604.

8. Kitano M, Kudo M, Yamao K, et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol. 2012; 107:303–310.

9. Fusaroli P, Spada A, Mancino MG, Caletti G. Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses. Clin Gastroenterol Hepatol. 2010; 8:629–634. e1-e2.

10. Napoleon B, Alvarez-Sanchez MV, Gincoul R, et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy. 2010; 42:564–570.

11. Sugimoto M, Takagi T, Hikichi T, et al. Conventional versus contrast- enhanced harmonic endoscopic ultrasonography-guided fine-needle aspiration for diagnosis of solid pancreatic lesions: a prospective randomized trial. Pancreatology. 2015; 15:538–541.

12. Kitano M, Kamata K. Contrast-enhanced harmonic endoscopic ultrasound: future perspectives. Endosc Ultrasound. 2016; 5:351–354.

13. Zhong N, Zhang L, Takahashi N, et al. Histologic and imaging features of mural nodules in mucinous pancreatic cysts. Clin Gastroenterol Hepatol. 2012; 10:192–198. e1-e2.

14. Harima H, Kaino S, Shinoda S, Kawano M, Suenaga S, Sakaida I. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography. World J Gastroenterol. 2015; 21:6252–6260.

15. Ohno E, Hirooka Y, Itoh A, et al. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg. 2009; 249:628–634.

16. Sofuni A, Itoi T, Itokawa F, et al. Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy. World J Gastroenterol. 2008; 14:7183–7191.

17. Matsui S, Kudo M, Kitano M, Asakuma Y. Evaluation of the response to chemotherapy in advanced gastric cancer by contrast-enhanced harmonic EUS. Hepatogastroenterology. 2015; 62:595–598.

18. Yamashita Y, Ueda K, Itonaga M, et al. Tumor vessel depiction with contrast-enhanced endoscopic ultrasonography predicts efficacy of chemotherapy in pancreatic cancer. Pancreas. 2013; 42:990–995.